We will use two human-adapted microbes that cause tremendous morbidity and mortality worldwide to explore the potential of organoid technology to study human-specific gastrointestinal bacterial pathogens. Helicobacter pylori (Hp) chronically infects the stomachs of over 50% of the world population and is the most important risk factor for the development of gastric cancer. Over 700,000 people die annually from gastric cancer. Salmonella enterica serovar Typhi (S. Typhi) infects more than 20 million people yearly and causes 220,000 deaths annually. Both pathogens can persist over long periods of time in the human host, neither have an animal reservoir, and both manipulate the epithelium and the immune system in sophisticated ways. Each is adapted to a different region of the gastrointestinal tract, and thus will serve as important test cases for infection of different types of human organoids (gastric, small intestine, and colon). There are a number of unanswered questions that cannot be properly addressed in animal models. For example, it is unknown whether the injection of the Hp virulence factor CagA into gastric cells promotes gastric cancer. In vitro, Hp and CagA accelerate epithelial cell proliferation, disrupt the intercellular junctions, alter cell polarity, prevent apoptosis, and induce inflammatory responses. We will use human gastric organoids to determine whether Hp injects CagA in the human gastric glands and how it affects proliferating precursor cells in human epithelium. Another unanswered question in the field is how does Salmonella Typhi invade the intestine without causing acute gastroenteritis? To begin addressing these questions we propose to 1) use gastric organoids to model the interaction between Hp and the human gastric epithelium and focus on its effects on precursor/stem cells and 2) ask how does S.Typhi control immune responses in the gut to manipulate inflammatory signaling and avoid causing acute gastroenteritis.

Public Health Relevance

PROJECT RELEVANCE Helicobacter pylori and Salmonella Typhi are human-adapted gastrointestinal pathogens that are difficult to study in animal models. Together they are responsible for over one million deaths from stomach cancer and typhoid fever each year. We will use human gastric and intestinal organoids as models of infection to understand their pathogenic effects on human gastrointestinal tissue.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI116484-03
Application #
9221985
Study Section
Special Emphasis Panel (ZAI1-LG-M)
Project Start
Project End
Budget Start
2017-03-01
Budget End
2018-02-28
Support Year
3
Fiscal Year
2017
Total Cost
$251,841
Indirect Cost
$90,551
Name
Stanford University
Department
Type
Domestic Higher Education
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Wosen, Jonathan E; Mukhopadhyay, Dhriti; Macaubas, Claudia et al. (2018) Epithelial MHC Class II Expression and Its Role in Antigen Presentation in the Gastrointestinal and Respiratory Tracts. Front Immunol 9:2144
Hartmann, Felix J; Simonds, Erin F; Bendall, Sean C (2018) A Universal Live Cell Barcoding-Platform for Multiplexed Human Single Cell Analysis. Sci Rep 8:10770
Ding, Siyuan; Zhu, Shu; Ren, Lili et al. (2018) Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells. Elife 7:
Haugh, Matthew G; Vaughan, Ted J; Madl, Christopher M et al. (2018) Investigating the interplay between substrate stiffness and ligand chemistry in directing mesenchymal stem cell differentiation within 3D macro-porous substrates. Biomaterials 171:23-33
Keren, Leeat; Bosse, Marc; Marquez, Diana et al. (2018) A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. Cell 174:1373-1387.e19
LeSavage, Bauer L; Suhar, Nicholas A; Madl, Christopher M et al. (2018) Production of Elastin-like Protein Hydrogels for Encapsulation and Immunostaining of Cells in 3D. J Vis Exp :
Madl, Christopher M; Heilshorn, Sarah C; Blau, Helen M (2018) Bioengineering strategies to accelerate stem cell therapeutics. Nature 557:335-342
Nair, Nitya; Feng, Ningguo; Blum, Lisa K et al. (2017) VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. Sci Transl Med 9:
Dubbin, Karen; Tabet, Anthony; Heilshorn, Sarah C (2017) Quantitative criteria to benchmark new and existing bio-inks for cell compatibility. Biofabrication 9:044102
Janda, Claudia Y; Dang, Luke T; You, Changjiang et al. (2017) Surrogate Wnt agonists that phenocopy canonical Wnt and ?-catenin signalling. Nature 545:234-237

Showing the most recent 10 out of 31 publications